We measure our success in the value of human life.

FIT Biotech

FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology and GTU® product applications in DNA vaccination as well as in immuno- and gene therapies.

News and Events

In Memoriam

FIT Biotech pays tribute to Professor Joep Lange
Read more

Lehdistötiedote, 16.6.2014

FIT BIOTECH JA LEUVEN LUOVAT UUSIA MAHDOLLISUUKSIA GEENITERAPIALLE
Lue lisää

Press release, June-16-2014

KU Leuven and FIT Biotech demonstrate promise in antibody gene therapy and expand their collaboration to include enzyme replacement treatment.
Read more

Lehdistötiedote, 28.02.2014

FIT BIOTECHIN RAHOITUSKIERROS YLITTI MILJOONAN EURON RAJAN
Lue lisää

Research and Development

Research & Development

FIT Biotech's most important R&D activity since the start of its operations has been the development of an HIV vaccine.

 

R&D Publications